They are trying to solve the problem of gigantic markups - because of legal monopolies through patents - on advanced chemical products where dosage and quality control is literally life or death. Their solution is to do it yourself in a garage.
Couldn’t they at least tried parallel imports from quality controlled production in countries with less gigantic markups?
Or, if they could have stopped playing Robin Hood for a second and looked at the systemic problems instead, there was a proposal at WHO some ten years ago to reform pharmaceutical research and development with direct funding and then releasing the results, basically creating a direct to generica pipeline. The US shot it down, of course, which means public relations campaigns in the US would be great. But no, DIY in the garage.
(If anyone is interested in details the proposal was called “delinkage”.)
They are trying to solve the problem of gigantic markups - because of legal monopolies through patents - on advanced chemical products where dosage and quality control is literally life or death. Their solution is to do it yourself in a garage.
Couldn’t they at least tried parallel imports from quality controlled production in countries with less gigantic markups?
Or, if they could have stopped playing Robin Hood for a second and looked at the systemic problems instead, there was a proposal at WHO some ten years ago to reform pharmaceutical research and development with direct funding and then releasing the results, basically creating a direct to generica pipeline. The US shot it down, of course, which means public relations campaigns in the US would be great. But no, DIY in the garage.
(If anyone is interested in details the proposal was called “delinkage”.)